Quantum BioPharma Ltd. (CSE:QNTM)

Canada flag Canada · Delayed Price · Currency is CAD
9.45
-0.54 (-5.41%)
At close: Jan 20, 2026
92.86%
Market Cap36.24M
Revenue (ttm)n/a
Net Income (ttm)-39.71M
Shares Out3.83M
EPS (ttm)-14.06
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume219
Average Volume3,865
Open9.45
Previous Close9.99
Day's Range9.45 - 9.45
52-Week Range4.20 - 52.00
Beta0.72
RSI40.60
Earnings DateMar 27, 2026

About Quantum BioPharma

Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. It operates through two segments, Biopharmaceutical Innovation and Strategic Investments. The company researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1998
Employees 17
Stock Exchange Canadian Securities Exchange
Ticker Symbol QNTM
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements